ENVB · Enveric Biosciences, Inc.
$1.33
+0.00 (+0.00%)
At close · Jul 29
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year from the issuance of these unaudited condensed consolidated financial statements.”View the 10-Q filed May 15, 2026
Market Cap
$4.90M
Shares
3.68M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-05-04 | New | Biotechnology | $5,000,002 | $5,000,002 | 06b |
| 2026-02-11 | New | Biotechnology | $1,450,017 | $1,450,017 | 06b |
| 2025-12-23 | New | Biotechnology | $106,598 | $106,598 | 06b |
| 2025-10-03 | New | Pharmaceuticals | Indefinite | $0 | 06b |
| 2023-04-19 | Amendment | Pharmaceuticals | $12,780,000 | $12,780,000 | 06b |
| 2022-08-05 | New | Pharmaceuticals | $8,617,500 | $8,617,500 | 06b |
| 2021-02-24 | New | Pharmaceuticals | $8,398,625 | $0 | 06b |
| 2021-01-20 | New | Pharmaceuticals | $8,249,959 | $0 | 06b |
Showing 1–8 of 8 filings